McKesson Crecimiento futuro

Future controles de criterios 2/6

Se prevé un crecimiento anual de los beneficios y los ingresos de McKesson de 8.7% y 7.9% por año respectivamente. Se prevé que el BPA crezca en un 13.6% al año. Se espera que la rentabilidad financiera sea de 222.4% en 3 años.

Información clave

8.7%

Tasa de crecimiento de los beneficios

13.7%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Healthcare	17.2%
Tasa de crecimiento de los ingresos	7.9%
Rentabilidad financiera futura	222.4%
Cobertura de analistas	Good
Última actualización	02 May 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

McKesson Non-GAAP EPS of $6.90 beats by $0.54, revenue of $70.5B misses by $480M

Feb 01

McKesson Corporation's (NYSE:MCK) Intrinsic Value Is Potentially 33% Above Its Share Price

Jan 12

5 Reasons Why I Am Considering Adding McKesson To My Portfolio

Dec 27

McKesson Corporation: Still Trading Below Intrinsic Value

Dec 13

Duration: The Time Bomb In Your Portfolio - McKesson And PayPal In Focus

Oct 08

McKesson extends distribution partnership with CVS Health

Sep 29

An Intrinsic Calculation For McKesson Corporation (NYSE:MCK) Suggests It's 50% Undervalued

Sep 19

McKesson to acquire Rx Savings Solutions in $875M deal

Sep 19

Cardinal Health, McKesson hit 52-week highs; up 35% and 50% YTD

Aug 15

McKesson raises fiscal 2023 adjusted diluted EPS following strong quarterly results

Aug 03

McKesson raises dividend by 15% to $0.54/share

Jul 25

McKesson Is Still An Attractive Dividend Growth Stock

Jul 10

McKesson: Best Of Breed In Drug Distributor Oligopoly

Jun 20

McKesson: Still Profitable Without COVID-19 Boosts

Jun 04

Previsiones de crecimiento de beneficios e ingresos

NYSE:MCK - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
3/31/2027	398,616	4,053	5,717	6,417	3
3/31/2026	363,712	3,706	5,044	5,599	13
3/31/2025	338,037	3,526	4,892	5,467	14
3/31/2024	311,914	3,034	3,421	3,956	14
12/31/2023	301,506	2,998	2,892	3,492	N/A
9/30/2023	291,098	3,487	4,306	4,906	N/A
6/30/2023	284,040	3,755	4,466	5,048	N/A
3/31/2023	276,711	3,563	4,601	5,159	N/A
12/31/2022	273,903	3,146	4,190	4,721	N/A
9/30/2022	272,027	2,061	3,952	4,430	N/A
6/30/2022	268,446	1,396	4,639	5,115	N/A
3/31/2022	263,966	1,119	3,899	4,434	N/A
12/31/2021	257,006	1,415	4,323	4,917	N/A
9/30/2021	250,991	-4,804	4,098	4,753	N/A
6/30/2021	245,223	-4,494	3,299	3,982	N/A
3/31/2021	238,228	-4,538	3,901	4,542	N/A
12/31/2020	237,621	-4,189	5,231	5,826	N/A
9/30/2020	234,194	2,228	3,905	4,492	N/A
6/30/2020	231,002	922	2,851	3,363	N/A
3/31/2020	231,051	906	3,868	4,374	N/A
12/31/2019	224,945	-905	3,125	3,615	N/A
9/30/2019	221,981	-626	3,066	3,559	N/A
6/30/2019	217,440	601	4,523	5,046	N/A
3/31/2019	214,319	33	3,479	4,036	N/A
12/31/2018	213,518	-319	2,572	3,165	N/A
9/30/2018	210,927	113	2,751	3,324	N/A
6/30/2018	209,913	-384	1,936	2,543	N/A
3/31/2018	208,357	62	3,765	4,345	N/A
12/31/2017	205,442	4,805	2,171	2,756	N/A
9/30/2017	201,955	4,539	N/A	3,155	N/A
6/30/2017	199,851	4,846	N/A	3,626	N/A
3/31/2017	198,533	5,194	N/A	4,744	N/A
12/31/2016	196,498	2,051	N/A	6,415	N/A
9/30/2016	194,267	2,044	N/A	5,349	N/A
6/30/2016	193,071	2,359	N/A	5,077	N/A
3/31/2016	190,884	2,290	N/A	3,672	N/A
12/31/2015	189,131	2,237	N/A	2,449	N/A
9/30/2015	187,716	2,090	N/A	4,198	N/A
6/30/2015	183,115	1,950	N/A	3,384	N/A
3/31/2015	179,045	1,775	N/A	3,112	N/A
12/31/2014	171,952	1,780	N/A	3,893	N/A
9/30/2014	159,804	1,462	N/A	2,488	N/A
6/30/2014	148,629	1,402	N/A	2,602	N/A
3/31/2014	137,392	1,419	N/A	3,136	N/A
12/31/2013	130,076	1,278	N/A	2,679	N/A
9/30/2013	126,839	1,420	N/A	2,837	N/A
6/30/2013	123,609	1,396	N/A	3,751	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (8.7% al año) de MCK es superior a la tasa de ahorro (2.3%).

Beneficios vs. Mercado: Se prevé que los beneficios (8.7% al año) de MCK crezcan menos que el mercado US (14.7% al año).

Beneficios de alto crecimiento: Se prevé que los beneficios de MCK crezcan, pero no significativamente.

Ingresos vs. Mercado: Se prevé que los ingresos (7.9% al año) de MCK crezcan más despacio que el mercado de US (8.1% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 7.9% al año) de MCK crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de MCK sea muy elevada dentro de 3 años (222.4%).

McKesson Crecimiento futuro

Future controles de criterios 2/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Price target increased to US$354

Recent updates

Third quarter dividend of US$0.62 announced

McKesson Corporation Declares Quarterly Dividend, Payable on June 3, 2024

McKesson Corporation to Report Q4, 2024 Results on May 07, 2024

CEO & Director notifies of intention to sell stock

Is McKesson Corporation (NYSE:MCK) Trading At A 43% Discount?

Upcoming dividend of US$0.62 per share

McKesson: GLP-1 Contributed More Than 1/3 Of Growth

McKesson's (NYSE:MCK) Profits May Not Reveal Underlying Issues

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Second quarter dividend of US$0.62 announced

High number of new directors

Mckesson Corporation Declares Quarterly Dividend, Payable on April 1, 2024

Investor Optimism Abounds McKesson Corporation (NYSE:MCK) But Growth Is Lacking

McKesson: Why The Company Is Too Richly Valued

McKesson Corporation Reportedly Seeks Buyers for Canada's Rexall Pharmacy

McKesson Corporation (NYSE:MCK) acquired Compile, Inc.

Mckesson Corporation Elects Kevin Ozan as New Director

CEO & Director notifies of intention to sell stock

McKesson Corporation to Report Q3, 2024 Results on Feb 07, 2024

McKesson Appoints Crystal Lennartz to Health Mart and Health Mart Atlas

Upcoming dividend of US$0.62 per share at 0.5% yield

If EPS Growth Is Important To You, McKesson (NYSE:MCK) Presents An Opportunity

CEO & Director notifies of intention to sell stock

McKesson: GLP-1 Medications Tailwinds And Massive Share Repurchase

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

McKesson Corporation Announces Management Changes

Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 44%?

McKesson Corporation Declares Quarterly Dividend, Payable on January 2, 2024

CEO & Director notifies of intention to sell stock

McKesson Corporation to Report Q2, 2024 Results on Nov 01, 2023

McKesson: Still Trading For A Huge Discount

Upcoming dividend of US$0.62 per share at 0.6% yield

Here's Why McKesson (NYSE:MCK) Has Caught The Eye Of Investors

CEO & Director notifies of intention to sell stock

CEO & Director notifies of intention to sell stock

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 29%?

McKesson Corporation Raises Quarterly Dividend, Payable on October 2, 2023

CEO & Director notifies of intention to sell stock

McKesson Corporation to Report Q1, 2024 Results on Aug 02, 2023

McKesson: Outlook Remains Positive, I Reiterate My Buy Recommendation

McKesson Unveils New Private Brand of Over-the-Counter Pharmacy Products

CEO & Director notifies of intention to sell stock

McKesson Corporation, Annual General Meeting, Jul 21, 2023

McKesson Corporation, Annual General Meeting, Jul 21, 2023

Executive VP exercised options and sold US$424k worth of stock

Upcoming dividend of US$0.54 per share at 0.5% yield

Here's Why McKesson (NYSE:MCK) Has Caught The Eye Of Investors

CEO & Director notifies of intention to sell stock

Full year 2023 earnings: Revenues and EPS in line with analyst expectations

Are Investors Undervaluing McKesson Corporation (NYSE:MCK) By 32%?

Senior VP exercised options and sold US$88k worth of stock

Do McKesson's (NYSE:MCK) Earnings Warrant Your Attention?

Upcoming dividend of US$0.54 per share at 0.6% yield

McKesson Corporation: Looking Forward To Long-Term Low-Teens EPS Growth

CEO & Director notifies of intention to sell stock

Third quarter 2023 earnings: EPS exceeds analyst expectations

McKesson Non-GAAP EPS of $6.90 beats by $0.54, revenue of $70.5B misses by $480M

McKesson Corporation Declares Regular Dividend on Common Stock, Payable on April 3, 2023

McKesson Corporation's (NYSE:MCK) Intrinsic Value Is Potentially 33% Above Its Share Price

McKesson Corporation to Report Q3, 2023 Results on Feb 01, 2023

5 Reasons Why I Am Considering Adding McKesson To My Portfolio

Executive VP notifies of intention to sell stock

McKesson Corporation: Still Trading Below Intrinsic Value

Upcoming dividend of US$0.54 per share

Executive VP notifies of intention to sell stock

Insider notifies of intention to sell stock

High number of new directors

Insider exercised options and sold US$141k worth of stock

Second quarter 2023 earnings: EPS exceeds analyst expectations

McKesson Corporation Declares Quarterly Dividend, Payable on January 3, 2023

Executive VP notifies of intention to sell stock

Duration: The Time Bomb In Your Portfolio - McKesson And PayPal In Focus